Biotech

All Articles

Former Seagen CEO reveals new startup Ottimo Pharma

.After antibody-drug conjugate (ADC) professional Seagen was actually sold to Pfizer in 2013 for a m...

Ironwood makes additional purpose $1B GI medicine with brand-new subgroup information

.On the heels of a phase 3 gain that neglected to impress real estate investors, Ironwood Pharmaceut...

Novartis inks $150M offer for autoimmune molecular glue

.Do not stop Monte Rosa Therapeutics currently. The Boston-based biotech is having a ball after auth...

Jade takes exec team along with Chinook vets-- Chutes &amp Ladders

.Accept to recently's Chutes &amp Ladders, our summary of significant management hirings, firings an...

Septerna goes public with upsized offering of $288M

.Celebrating his business's upsized initial public offering (IPO), Septerna CEO Jeffrey Finer called...

AbbVie makes Richter wealthier, paying for $25M to constitute breakthrough treaty

.AbbVie has actually come back to the source of its antipsychotic giant Vraylar searching for one mo...

GenSight enters into last weeks of money runway as earnings stream slips by of grasp

.GenSight Biologics is actually weeks far from losing loan. Once more. The biotech simply has suffic...

AZ licenses thrown out rare condition drug to Monopar Therapies

.Monopar Rehabs is actually recouping a drug from the dump of AstraZeneca's uncommon condition pipe....

Arcus' brand-new HIF-2a information in renal cancer hint at prospective upper hand over Merck's Welireg, experts say

.Along with brand new information out on Arcus Biosciences' speculative HIF-2a inhibitor, one team o...

Roche bets up to $1B to increase Dyno gene treatment shipment contract

.After creating a genetics treatment relationship along with Dyno Therapeutics in 2020, Roche is bac...